Global Ocular Drug Delivery Market Growth 2023-2029

Global Ocular Drug Delivery Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Ocular Drug Delivery Industry Forecast” looks at past sales and reviews total world Ocular Drug Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected Ocular Drug Delivery sales for 2023 through 2029. With Ocular Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ocular Drug Delivery industry.

This Insight Report provides a comprehensive analysis of the global Ocular Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ocular Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ocular Drug Delivery market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ocular Drug Delivery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ocular Drug Delivery.

The global Ocular Drug Delivery market size is projected to grow from US$ 24130 million in 2022 to US$ 33910 million in 2029; it is expected to grow at a CAGR of 33910 from 2023 to 2029.

United States market for Ocular Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Ocular Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Ocular Drug Delivery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Ocular Drug Delivery players cover OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Ocular Drug Delivery market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others

Segmentation by application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ocular Drug Delivery market?

What factors are driving Ocular Drug Delivery market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ocular Drug Delivery market opportunities vary by end market size?

How does Ocular Drug Delivery break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.